|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date26 Aug 1959 |
|
MechanismOpioid receptors agonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date01 Jan 1913 |
An open label single dose pharmacokinetic study of Diamorphine Hydrochloride Nasal Spray (0.06mg/kg) in children - DIAPOP STUDY
An open label, single dose safety study of Diamorphine Hydrochloride Nasal Spray (0.1mg/kg) in children - DIASAFE STUDY
100 Clinical Results associated with Wockhardt UK Ltd.
0 Patents (Medical) associated with Wockhardt UK Ltd.
100 Deals associated with Wockhardt UK Ltd.
100 Translational Medicine associated with Wockhardt UK Ltd.